XML 38 R22.htm IDEA: XBRL DOCUMENT

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2014

The unaudited pro forma financial information below is for informational purposes only and is not indicative of the results of operations or financial condition that would have been achieved if the merger would have taken place at the beginning of each of the periods presented and should not be taken as indicative of the Company’s future results of operations or financial condition.

	Three Months Ended						Nine months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Operating loss	$	(27,155,197	)	$	(1,110,023	)	$	(49,912,152	)	$	(2,682,000	)
Loss per share	$	(1.53	)	$	(0.15	)	$	(4.53	)	$	(0.37	)

Mind-NRG

Aggregate Consideration Allocated to Assets Acquired and Liabilities Assumed

The aggregate consideration of $16.5 million has been allocated to assets acquired and liabilities assumed based on estimated fair values at the February 11, 2014 as follows:

Cash	$	1,167,869
Other assets		71,130
Goodwill		7,076,412
In-process research and development		15,200,000
Deferred tax liability		(5,970,560	)
Accrued expenses		(321,417	)
ProteoSys milestone payable		(681,600	)
	$	16,541,834

Sonkei

Aggregate Consideration Allocated to Assets Acquired and Liabilities Assumed

The aggregate consideration of $18.9 million has been allocated to assets acquired and liabilities assumed based on estimated fair values at the date of merger November 12, 2013 as follows:

Cash	$	631,478
Goodwill		7,792,987
In-process research and development		19,000,000
Accrued expenses		(334,423	)
Derivative liability		(3,476	)
Deferred taxes		(7,463,200	)
Convertible promissory notes (see Note 7)		(680,000	)
	$	18,943,366